Grantclosed🌐 United StatesPAR-24-099

NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)

National Institutes of Health

Details?

Posted: Jan 29, 2024
Response deadline: Nov 17, 2025, 12:00 AM UTC
Type: Grant
Category: 93.855
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-24-099

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

NEI Small Business Innovation Research (SBIR) Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U44-Clinical Trial Required)
United States · Dec 1, 2023
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
United States · Jun 20, 2024
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
United States · Jun 21, 2024
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
United States · Jan 10, 2025
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
United States · Jan 3, 2025
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
United States · Nov 6, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.